Olaparib combo improves PFS in metastatic prostate cancer

Frontline olaparib plus abiraterone/prednisone combo improves survival in patients with metastatic castration-resistant prostate cancer.
MDedge News

source https://www.medscape.com/s/viewarticle/olaparib-combo-improves-pfs-metastatic-prostate-cancer-2024a100027e?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?